Advertisement

The effects of dexmedetomidine on liver ischemia–reperfusion injury in rats

Published:December 10, 2012DOI:https://doi.org/10.1016/j.jss.2012.11.034

      Abstract

      Background

      Ischemia–reperfusion (IR) injury of the liver may cause various types of damage to hepatic tissues. It can affect the prognosis of patients and the success of an operation. Dexmedetomidine is a selective α2 receptor agonist. We investigated whether dexmedetomidine provides protection against IR-induced liver injury in rats.

      Methods

      Forty rats were divided equally into four groups. In group 1, the liver was manipulated after the laparotomy, and no occlusion of the vessels of the liver was performed. In group 2, once the abdomen was opened, 60 min of ischemia and 60 min of reperfusion were applied according to the segmental hepatic ischemia model. In group 3, 10 μg/kg of dexmedetomidine was injected into the peritoneal cavity 30 min before ischemia. In group 4, 100 μg/kg of dexmedetomidine was injected into the peritoneal cavity 30 min before ischemia. Further procedures in groups 3 and 4 were the same as those of group 2. After the experiment was completed, the rats were killed. Liver tissues were removed and stored until biochemical and histologic assessments were performed.

      Results

      The malondialdehyde level in group 2 was higher than that of groups 1, 3, and 4 (P = 0.001, P = 0.000, and P = 0.000, respectively). Superoxide dismutase, catalase, and glutathione levels in group 2 were lower than those in group 1 (P = 0.001, P = 0.027, and P = 0.014, respectively). Superoxide dismutase and catalase levels in group 4 were higher than those in group 2 (P = 0.002 and P = 0.000, respectively). GSH levels in groups 3 and 4 were higher than those in group 2 (P = 0.049 and P = 0.006, respectively). A lower glutathione peroxidase level was detected in groups 2 and 3 than that in group 1 (P = 000). Group 4 demonstrated an increase in glutathione peroxidase levels compared with group 3 (P = 0.014). The histologic injury scores in groups 2–4 were higher than those in group 1 (P = 0.003, P = 0.002, and P = 0.001, respectively). However, the histologic injury scores were lower in groups 3 and 4 than those in group 2 (P = 0.003 and P = 0.002, respectively).

      Conclusions

      This study showed that dexmedetomidine may protect the liver against IR injury in rats.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Surgical Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Abu-Amara M.
        • Yang S.Y.
        • Tapuria N.
        • Fuller B.
        • Davidson B.
        • Seifalian A.
        Liver ischemia/reperfusion injury: processes in inflammatory networks—a review.
        Liver Transpl. 2010; 16: 1016
        • Henderson J.M.
        Liver transplantation and rejection: an overview.
        Hepato-Gastroenterol. 1999; 46: 1482
        • Bahde R.
        • Spiegel H.U.
        Hepatic ischaemia-reperfusion injury from bench to bedside.
        Br J Surg. 2010; 97: 1461
        • Lai Y.C.
        • Tsai P.S.
        • Huang C.J.
        Effects of dexmedetomidine on regulating endotoxin-induced up-regulation of inflammatory molecules in murine macrophages.
        J Surg Res. 2009; 154: 212
        • Arslan M.
        • Çomu F.M.
        • Küçük A.
        • Öztürk L.
        • Yaylak F.
        Dexmedetomidine protects against lipid peroxidation and erythrocyte deformability alterations in experimental hepatic ischemia reperfusion injury.
        Libyan J Med. 2012; 7 (Epub 2012 May 24)https://doi.org/10.3402/ljm.v7i0.18185
        • Karaman A.
        • Fadillioglu E.
        • Turkmen E.
        • Tas E.
        • Yilmaz Z.
        Protective effects of leflunomide against ischemia-reperfusion injury of the rat liver.
        Pediatr Surg Int. 2006; 22: 428
        • Kaplowitz N.
        Mechanisms of liver cell injury.
        J Hepatol. 2000; 32: 39
        • Delva E.
        • Camus Y.
        • Nordlinger B.
        • et al.
        Vascular occlusion for liver resections. Operative management and tolerance to ischemia: 142 cases.
        Ann Surg. 1989; 209: 211
        • Dalle-Donne I.
        • Rossi R.
        • Colombo R.
        • Giustarini D.
        • Milzani A.
        Biomarkers of oxidative damage in human disease.
        Clin Chem. 2006; 652: 601
        • Ruffolo R.R.
        • Nichols A.J.
        • Stadel J.M.
        • Hieble J.P.
        Structure and function of alpha adrenoceptors.
        Pharmacol Rev. 1991; 43: 475
        • Hall S.R.
        • Wang L.
        • Milne B.
        • Hong M.
        Central dexmedetomidine attenuates cardiac dysfunction in a rodent model of intracranial hypertension.
        Can J Anaesth. 2004; 51: 1025
        • Terzı H.
        • Ozturk H.
        • Bugdaycı G.
        • Ozturk H.
        Beneficial effect of dexmedetomidine on testicular ischemia—reperfusion injury in rats.
        Adv Clin Exp Med. 2008; 17: 513
        • Kocoglu H.
        • Ozturk H.
        • Ozturk H.
        • Yılmaz F.
        • Gulcu N.
        Effect of dexmedetomidine on ischemia-reperfusion injury in rat kidney: a histopathologic study.
        Ren Fail. 2009; 31: 70
        • Zeng Z.
        • Huang H.F.
        • Chen M.Q.
        • Song F.
        • Zhang Y.J.
        Contributions of heme oxygenase-1 in postconditioning-protected ischemia-reperfusion injury in rat liver transplantation.
        Transplant Proc. 2011; 43: 2517
        • Yang L.Q.
        • Tao K.M.
        • Liu Y.T.
        • et al.
        Remifentanil preconditioning reduces hepatic ischemia–reperfusion injury in rats via inducible nitric oxide synthase expression.
        Anesthesiology. 2011; 114: 1036
        • Awad A.S.
        • Kamel R.
        • Sherief M.A.
        Effect of thymoquinone on hepatorenal dysfunction and alteration of CYP3A1 and spermidine/spermine N-1-acetyl-transferase gene expression induced by renal ischaemia–reperfusion in rats.
        J Pharm Pharmacol. 2011; 63: 1037
        • Engelhard K.
        • Werner C.
        • Kaspar S.
        • et al.
        Effect of alpha2-agonist dexmedetomidine on cerebral neurotransmitter concentrations during cerebral ischemia in rats.
        Anesthesiology. 2002; 96: 450
        • Laudenbach V.
        • Mantz J.
        • Lagercrantz H.
        • Desmonts J.M.
        • Evrard P.
        • Gressens P.
        Effects of alpha(2)-adrenoceptor agonists on perinatal excitotoxic brain injury: comparison of clonidine and dexmedetomidine.
        Anesthesiology. 2002; 96: 134
        • Sezer A.
        • Memiş D.
        • Usta U.
        • Süt N.
        The effect of dexmedetomidine on liver histopathology in a rat sepsis model: an experimental pilot study.
        Ulus Travma Acil Cerrahi Derg. 2010; 16: 108
        • Eser O.
        • Fidan H.
        • Sahin O.
        • et al.
        The influence of dexmedetomidine on ischemic rat hippocampus.
        Brain Res. 2008; 1218: 250
        • Venn R.M.
        • Bryant A.
        • Hall G.M.
        • Grounds R.M.
        Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post-operative patients needing sedation in the intensive care unit.
        Br J Anaesth. 2001; 86: 650
        • Ayoglu H.
        • Gul S.
        • Hanci V.
        • et al.
        The effects of dexmedetomidine dosage on cerebral vasospasm in a rat subarachnoid haemorrhage model.
        J Clin Neurosci. 2010; 17: 770
        • Can M.
        • Gul S.
        • Bektas S.
        • Hanci V.
        • Acikgoz S.
        Effects of dexmedetomidine or methylprednisolone on inflammatory responses in spinal cord injury.
        Acta Anaesthesiol Scand. 2009; 53: 1068